BIIB vs WFC · P/E 21, rev $9.89B vs P/E 15, rev $22.62B
Biogen Inc (BIIB) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported WFC revenue for 2026-06-30 was $22.62B. Net income was $6.41B. Revenue was up 5.5% from 2026-03-31 to 2026-06-30. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the BIIB and WFC stock pages for the full models.
Not investment advice.